Trade ConvaTec Group PLC - CTEC
ConvaTec Group PLC (CTEC) is a multinational medical technologies and products company headquartered in Reading, England. It is providing its customers with services and products in the areas of ostomy care, continence and critical care, wound and skin care, as well as supplying infusion devices. The company has over 9,000 employees and operations in more than 100 countries. The Convatec share price can be found on the London Stock Exchange and is included in the FTSE 250 Index. In 1978, the company was founded as one of the divisions of E.R. Squibb & Sons, Inc. By the following mergers and acquisitions, ConvaTec kept continuously growing into today’s large international business with annual revenue of $1.8 billion in 2018. Follow the CTEC share price in real time with Capital.com.Latest shares articles

BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026

TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026

Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026

Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026